Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

By using a detergent-washed membrane preparation, the interaction of the fungal natural product inhibitor aureobasidin A (AbA) with inositol phosphorylceramide synthase (IPC synthase) was studied by kinetic analysis of wild-type and mutant enzyme-catalyzed reactions. AbA inhibited the wild-type enzyme from both Candida albicans and Saccharomyces cerevisiae in an irreversible, time-dependent manner, with apparent K(i) values of 183 and 234 pM, respectively. Three synthetic chemistry-derived AbA derivatives, PHA-533179, PHA-556655, and PHA-556656, had affinities 4 to 5 orders of magnitude lower and were reversible inhibitors that competed with the donor substrate phosphatidylinositol (PI). AbA was a reversible, apparently noncompetitive inhibitor, with a K(i) of 1.4 microM, of the IPC synthase from an AbA-resistant S. cerevisiae mutant. The K(m) values for both substrates (ceramide and PI) were similar when they interacted with the mutant and the wild-type enzymes. By contrast, the V(max) for the mutant enzyme was less than 10% of that for the wild-type enzyme. A comparison of the results obtained with AbA with those obtained with two other natural products inhibitors, rustmicin and khafrefungin, revealed that while rustmicin appeared to be a reversible, noncompetitive inhibitor of the wild-type enzyme, with a K(i) of 16.0 nM, khafrefungin had the kinetic properties of a time-dependent inhibitor and an apparent K(i) of 0.43 nM. An evaluation of the efficiencies of these compounds as inhibitors of the mutant enzyme revealed for both a drop in the apparent affinity for the enzyme of more than 2 orders of magnitude.

Knowledge Graph

Similar Paper

Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A
Antimicrobial Agents and Chemotherapy 2009.0
Aureobasidins:  Structure−Activity Relationships for the Inhibition of the Human MDR1 P-Glycoprotein ABC-Transporter
Journal of Medicinal Chemistry 2000.0
Pleofungins, Novel Inositol Phosphorylceramide Synthase Inhibitors, from Phoma sp. SANK 13899
The Journal of Antibiotics 2007.0
Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A
ACS Medicinal Chemistry Letters 2015.0
Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans
Bioorganic & Medicinal Chemistry Letters 2021.0
Isolation, Structure, and Biological Activity of Phaeofungin, a Cyclic Lipodepsipeptide from a <i>Phaeosphaeria</i> sp. Using the Genome-Wide <i>Candida albicans</i> Fitness Test
Journal of Natural Products 2013.0
Isolation, Structure, and Biological Activity of Phaeofungin, a Cyclic Lipodepsipeptide from a <i>Phaeosphaeria</i> sp. Using the Genome-Wide <i>Candida albicans</i> Fitness Test
Journal of Natural Products 2013.0
Structures and Antifungal Activities of New Aureobasidins.
The Journal of Antibiotics 1995.0
Arborcandins A, B, C, D, E and F, Novel 1,3-.BETA.-Glucan Synthase Inhibitors. Production and Biological Activity.
The Journal of Antibiotics 2000.0
Isolation, structures, and antifungal activities of new aureobasidins.
The Journal of Antibiotics 1993.0